Could fecal calprotectin serve as an indicator of gastrointestinal (GI) complications in individuals with systemic sclerosis?
Preprint
- 1 September 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Introduction : Systemic sclerosis is a connective tissue disease with unpredictable symptoms. The GI tract is often affected, with calprotectin levels indicating inflammation. We are examining fecal calprotectin as a simple method to diagnose GI disorders and disease activity. Materials and methods We gathered information from the 39 patients by filling out a UCLA SCTS 2.0 questionnaire regarding their GI symptoms. Additionally, we examined their skin and determined their skin score. Blood samples were taken to assess malnutrition, and stool samples were collected to measure the calprotectin level. We also conducted a non-aggressive Barium Swallow and CT Enterography to check for GI disorders. Results Increased levels of FC didn’t have any correlation with age (P Value = 0.79), disease type (P Value = 0.59), slight intestine wall thickening (P Value = 0.10), esophageal dilatation (P Value = 0.18), skin score (P Value = 0.25), final GI score (P Value = 0.30) and none of the serum tests. In our study, just 5 cases had evidence of wall thickening in CT Enterography, and all those 5 cases had increased levels of calprotectin. Also, as most of our patients take vitamin and mineral supplements, we couldn’t find any signs of micronutrient deficiencies or correlation with FC level. Discussion and Conclusion: While no statistical correlation was found between FC level and the variables, the results suggest that FC might be a specific tool for assessing intestinal wall thickness. However, due to the limited sample size, further studies are necessary to validate these findings.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Barium Appendicitis 1 Month After a Barium MealInternational Surgery, 2013
- Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosisAutoimmunity Reviews, 2012
- Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational studyBMC Gastroenterology, 2012
- Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrumentArthritis Care & Research, 2009
- Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trialsRheumatology, 2009
- Watermelon stomach in systemic sclerosis: its incidence and managementAlimentary Pharmacology & Therapeutics, 2008
- Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitisEuropean Journal of Gastroenterology & Hepatology, 2008
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJournal of Clinical Investigation, 2007
- Scleroderma: from cell and molecular mechanisms to disease modelsTrends in Immunology, 2005
- Systemic Sclerosis Mortality in the United States: 1979–1998European Journal of Epidemiology, 2005